3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
3
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Breast Neoplasms
2
Urologic Neoplasms
1
Thyroid Neoplasms
1
Soft Tissue Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdomyosarcoma
1
Recurrence
1
Pharyngeal Neoplasms
1
Patients With Advanced or Metastatic Solid Tumors
1
PRETEXT I Hepatoblastoma
1
Neurofibromatosis 2
1
Neoplasms, Mesothelial
1
Mouth Neoplasms
1
Melanoma
1
Lymphangioleiomyomatosis
1
Lung Neoplasms
1
Kidney Neoplasms
1
Glioma
1
Glioblastoma
1
Erdheim-Chester Disease
1
Endometrial Adenocarcinoma
1
Endocrine Gland Neoplasms
1
Colonic Neoplasms
1
Castleman Disease
1
Interventions
Brachytherapy
2
trastuzumab deruxtecan
1
liposomal doxorubicin
1
entinostat
1
dostarlimab
1
bintrafusp alfa protein, human
1
Therapeutic Touch
1
Surveys and Questionnaires
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiation
1
Platinum
1
Paclitaxel
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Gemcitabine
1
Doxorubicin
1
Dehydroepiandrosterone
1
Congresses as Topic
1
Cisplatin
1
Bupropion
1
Bevacizumab
1
Axitinib
1
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Vaginal Neoplasms
×
temsirolimus
×
90 days
×
Clear all
No trials found.